WeVote
Log In

Bill

Bill

LB 866

Change distribution of the Nebraska Opioid Recovery Trust Fund, create a fund, and provide for drug detection activities

109th Legislature (2025-2026) Introduced by Beau Ballard

LB 866 redirects Nebraska's opioid settlement funds among state programs and establishes drug detection activities to address ongoing opioid and substance abuse challenges.

Notice of hearing for January 30, 2026
0
WeVote Research Nonpartisan
Bill Summary · LB 866

Legislative bill overview

LB 866 modifies how Nebraska's Opioid Recovery Trust Fund—money received from opioid litigation settlements—is distributed among state agencies and programs. The bill creates a new fund and establishes provisions for drug detection activities, likely expanding the state's capacity to identify and respond to opioid and other drug threats.

Why is this important

Opioid settlement funds are finite resources that states must allocate strategically across prevention, treatment, recovery support, and enforcement. How Nebraska restructures these distributions will determine which communities, programs, and interventions receive prioritized funding as the state continues addressing its opioid crisis.

Potential points of contention

  • Fund allocation priorities: Different stakeholders (treatment providers, law enforcement, harm reduction advocates, local governments) may compete for limited settlement dollars and disagree on which interventions offer the best return on investment
  • Drug detection scope and cost: Expanding drug detection activities could mean increased surveillance or testing capacity; unclear whether funding is adequate or if this diverts resources from treatment and prevention
  • Geographic equity: Rural versus urban areas may have different access to the new fund's resources, and the bill's specifics on distribution formulas remain unclear from available information

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.